Dexamethasone inhibits TRAIL-induced apoptosis of thyroid cancer cells via Bcl-xL induction
- 1 December 2006
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (18) , 3287-3293
- https://doi.org/10.1016/j.ejca.2006.07.018
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Annexin-1 downregulation in thyroid cancer correlates to the degree of tumour differentiationCancer Biology & Therapy, 2006
- Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cellsCell Death & Differentiation, 2005
- Apoptosis-based therapies and drug targetsCell Death & Differentiation, 2005
- Glucocorticoids Inhibit Apoptosis during Fibrosarcoma Development by Transcriptionally Activating Bcl-xLJournal of Biological Chemistry, 2003
- Apo2L/TRAIL and its death and decoy receptorsCell Death & Differentiation, 2003
- A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometryPublished by Elsevier ,2002
- Antiapoptotic effect of nicorandil mediated by mitochondrial atp-sensitive potassium channels in cultured cardiac myocytesJournal of the American College of Cardiology, 2002
- Recent insights into the mechanism of glucocorticosteroid-induced apoptosisCell Death & Differentiation, 2002
- TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic interventionOncogene, 2000
- Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivoNature Medicine, 1999